Last viewed: abvc


Prices are updated after-hours


nasdaq:ABVC ABVC BioPharma Inc

ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade

(0.0% 1d) (-52.2% 1m) (-80.9% 1y) (0.0% 2d) (0.7% 3d) (0.7% 7d) (-38.21% volume)
Earnings Calendar:

Sec Filling | Patents | 34 employees



adhd  

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
Published: 2022-06-21 (Crawled : 13:20) - biospace.com/
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 6.64% H: 0.0% C: 0.0%

partnership biopharma corporation
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
Published: 2022-06-16 (Crawled : 13:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: -4.85% H: 4.08% C: -1.86%

vitargus biopharma australia
ABVC BioPharma Announces Termination of Two Contracts
Published: 2022-06-10 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: -2.15% H: 0.0% C: 0.0%

biopharma
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: -1.01% H: 4.59% C: 3.32%

biopharma for adhd
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
Published: 2022-05-25 (Crawled : 13:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 0.97% H: 0.96% C: -1.92%

biopharma biotech license
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
Published: 2022-05-23 (Crawled : 12:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 6.76% H: 5.43% C: -2.26%

services depression
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
Published: 2022-05-16 (Crawled : 22:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 3.3% H: 0.0% C: -4.56%

biopharma results
WallachBeth Capital Announces Completion of ABVC BioPharma, Inc. (Nasdaq: ABVC) $4.22 Million Registered Direct Offering
Published: 2022-05-16 (Crawled : 20:00) - prnewswire.com
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 3.3% H: 0.0% C: -4.56%

offering nasdaq
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
Published: 2022-05-13 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: -9.75% H: 7.38% C: 5.63%

biopharma grant funding group
ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Treated
Published: 2022-05-10 (Crawled : 13:20) - biospace.com/
ABVC | $0.9465 0.69% -4.03% | twitter stocktwits trandingview |
Wholesale Trade
| | O: 2.0% H: 9.19% C: 6.11%

biopharma adhd
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 2.22% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% 0.86% | twitter stocktwits trandingview |
Electronic Technology
| 16:00